Genstar Capital has promoted James Nadauld to principal. Nadauld joined the firm in 2004 as a senior associate, and was later promoted to vice president. He focuses on the healthcare sector, and currently serves on the board of Genstar portfolio companies Oncure Medical Corp. and Univita Health Inc.
Genstar Capital, LLC, a middle market private equity firm that focuses on investments in selected segments of the life sciences and healthcare services, industrial technology, business services and software services industries, today announced the promotion of James D. Nadauld to Principal.
Mr. Nadauld, who focuses on investments in the healthcare services sector, joined Genstar in 2004 as Senior Associate and most recently served as Vice President. He currently serves on the Boards of Genstar portfolio companies Oncure Medical Corp. and Univita Health, Inc. and is a former director of Axia Health management, a Genstar portfolio company sold in 2006.
“A majority of our portfolio investments in our current and prior fund are in healthcare and healthcare related businesses and James has played a significant role in developing a number of those companies,” said Jean-Pierre L. Conte, Chairman and Managing Director of Genstar. “We will continue to emphasize this growing industry sector and expect James to play an increasing role as we continue to grow the firm and build long term value within our portfolio.”
Prior to joining Genstar, Mr. Nadauld was an Associate with MedEquity Investors, LLC, a healthcare-focused private equity firm. Previously, he was an Investment Banking Analyst in the Global Healthcare Group at Lehman Brothers, Inc. He earned an MBA from Harvard Business School and a BA in English from Brigham Young University.
About Genstar Capital, LLC
Genstar Capital (www.gencap.com) is a leading private equity firm that for over 20 years has been actively investing in high quality middle-market companies and building value in those businesses by utilizing the expertise of its operating partners. Based in San Francisco, Genstar works in partnership with its management teams and its network of operating partners and strategic advisors to transform its portfolio companies into industry-leading businesses. Genstar has more than $3 billion of committed capital under management and targets investments focused on selected sectors within the life science, healthcare services, industrial technology, software, and business services industries.